Polymorphisms of tumor necrosis factor-α promoter region for susceptibility to HLA-B27-positive ankylosing spondylitis in Korean population

Rheumatology International

Volumn 31, Issue 9, 2011, Pages 1167-1175

  Chung, Won Tae ^a   Choe, Jung Yoon ^b,c   Jang, Won Cheoul ^d   Park, Su Min ^d   Ahn, Young Chang ^d   Yoon, Il Kyu ^d   Kim, Tae Hwan ^e   Nam, Youn Hyoung ^f   Park, Sung Hoon ^b,c   Lee, Sung Won ^a   Kim, Seong Kyu ^b,c  

^a Dong A University College of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Catholic University of Daegu   (South Korea)

^d Dankook University   (South Korea)

^e Hanyang University Hospital for Rheumatic Diseases   (South Korea)

^f UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Ankylosing spondylitis; HLA B27; Polymorphism; Promoter; TNF

Indexed keywords

HLA B27 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-B27 ANTIGEN; HUMANS; MALE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80054961927     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1434-1     Document Type: Article

References (28)

1. Khan MA (2002) Update on spondyloarthropathies. Ann Intern Med 136:896-907
2. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A et al (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthr-opathy. Arthritis Rheum 34:1218-1230
3. Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD (1973) Ankylosing spondylitis and HL-A 27. Lancet 1:904-907
4. McGarry F, Neilly J, Anderson N, Sturrock R, Field M (2001) A polymorphism within the interleukin 1 receptor antagonist (IL-1Ra) gene is associated with ankylosing spondylitis. Rheumatology (Oxford) 40:1359-1364
5. Beyeler C, Armstrong M, Bird HA, Idle JR, Daly AK (1996) Relationship between genotype for the cytochrome P450 CYP2D6 and susceptibility to ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis 55:66-68
6. Crane AM, Bradbury L, van Heel DA, McGovern DP, Brophy S, Rubin L et al (2002) Role of NOD2 variants in spondylarthritis. Arthritis Rheum 46:1629-1633 (Pubitemid 34620211)
7. François RJ, Neure L, Sieper J, Braun J (2006) Immunohisto-logical examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor a in two patients with early disease and transforming growth factor a in three more advanced cases. Ann Rheum Dis 65:713-720 (Pubitemid 43799168)
8. Braun J, Deodhar A, Dijkmans B, Geusens P, Sieper J, Williamson P et al (2008) Ankylosing spondylitis study for the evaluation of Recombinant Infliximab Therapy Study Group. Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period. Arthritis Rheum 59:1270-1278
9. Davis JC Jr, van der Heijde DM, Braun J, Dougados M, Clegg DO, Kivitz AJ et al (2008) Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis. Ann Rheum Dis 67:346-352 (Pubitemid 351281269)
10. Rudwaleit M, Siegert S, Yin Z, Erick J, Thiel A, Radbruch A et al (2001) Low T cell production of TNF-α and IFN-c in ankylosing spondylitis: its relation to HLA-B27 and influence of the-308 TNF polymorphism. Ann Rheum Dis 60:36-42 (Pubitemid 32038951)
11. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW (1993) An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 177:557-560 (Pubitemid 23117109)
12. Lv K, Chen R, Cai Q, Fang M, Sun S (2006) Effects of a single nucleotide polymorphism on the expression of human tumor necrosis factor-alpha. Scand J Immunol 64:164-169 (Pubitemid 44034321)
13. Höhler T, Schäper T, Schneider PM, Meyer zum Büschenfelde KH, Märker-Hermann E (1998) Association of different tumor necrosis factor a promoter allele frequencies with ankylosing spondylitis in HLA-B27-positive individuals. Arthritis Rheum 41:1489-1492 (Pubitemid 28373130)
14. McGarry F, Walker R, Sturrock RD, Field M (1999) The-308.1 polymorphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis independent of HLA-B27. J Rheumatol 26:1110-1116 (Pubitemid 29215076)
15. Kaijzel EL, Brinkman BM, van Krugten MV, Smith L, Huizinga TW, Verjans GM et al (1999) Polymorphism within the tumor necrosis factor-a(TNF-α) promoter region in patients with anky-losing spondylitis. Hum Immunol 60:140-144 (Pubitemid 29072097)
16. Verjans GM, Brinkmann BMN, van Doornick CEM, Kijlstra A, Verweij CL (1994) Polymorphism of tumor necrosis factor-alpha (TNF-α) at position-308 in relation to ankylosing spondylitis. Clin Exp Immunol 97:45-47 (Pubitemid 24244053)
17. Fraile A, Nieto A, Beraun Y, Vinasco J, Matarán L, Martín J (1998) Tumor necrosis factor gene polymorphisms in ankylosing spondylitis. Tissue Antigens 51:386-1390
18. Shiau MY, Lo MK, Chang CP, Yang TP, Ho KT, Chang YH (2007) Association of tumour necrosis factor a promoter polymorphisms with ankylosing spondylitis in Taiwan. Ann Rheum Dis 66:562-563
19. Zhu X, Wang Y, Sun L, Song Y, Sun F, Tang L et al (2007) A novel gene variation of TNFa associated with ankylosing spon-dylitis: a reconfirmed study. Ann Rheum Dis 66:1419-1422 (Pubitemid 350032646)
20. van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361-368 (Pubitemid 14134775)
21. *27 typing by PCR-restriction fragment length polymorphism. Tissue Antigens 49:283-286 (Pubitemid 27122577)
22. Chang HK, Jang WC, Park SB, Nam YH, Lee SS, Park YW et al (2007) The novel-G646A polymorphism of the TNF-α promoter is associated with the HLA-B51 allele in Korean patients with Behçet's disease. Scand J Rheumatol 36:216-221 (Pubitemid 47174547)
23. Jung HY, Park JS, Park YJ, Kim YJ, Kimm K, Koh IS (2004) HapAnalyzer: minimum haplotype analysis system for association studies. Genomics Inform 2:107-109
24. El-Shabrawi Y, Wegscheider BJ, Weger M, Renner W, Posch U, Ulrich S, Ardjomand N et al (2006) Polymorphisms within the tumor necrosis factor-alpha promoter region in patients with HLA-B27-associated uveitis: association with susceptibility and clinical manifestations. Ophthalmology 113:695-700
25. Kuo NW, Lympany PA, Menezo V, Lagan AL, John S, Yeo TK et al (2005) TNF-857T, a genetic risk marker for acute anterior uveitis. Invest Ophthalmol Vis Sci 46:1565-1571 (Pubitemid 44843587)
26. Spies T, Morton CC, Nedospasov SA, Fiers W, Pious D, Strominger JL (1986) Genes for the tumor necrosis factors a and b are linked to the human major histocompatibility complex. Proc Natl Acad Sci USA 83:8699-8702 (Pubitemid 17194933)
27. Campbell RD, Trowsdale J (1993) Map of the human MHC. Immunol Today 14:349-352 (Pubitemid 23198168)
28. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO (1990) Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 87:1233-1237